A detailed history of Pentwater Capital Management LP transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Pentwater Capital Management LP holds 5,975,000 shares of PSTX stock, worth $56.5 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,975,000
Previous 5,975,000 -0.0%
Holding current value
$56.5 Million
Previous $17.4 Million 2.06%
% of portfolio
0.18%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.43 - $4.51 $2.45 Million - $4.55 Million
1,007,773 Added 20.29%
5,975,000 $21.1 Million
Q4 2020

Feb 16, 2021

BUY
$8.29 - $11.7 $727,339 - $1.03 Million
87,737 Added 1.8%
4,967,227 $54.5 Million
Q3 2020

Dec 09, 2020

BUY
$8.09 - $16.25 $20 Million - $40.1 Million
2,468,087 Added 102.35%
4,879,490 $43.3 Million
Q3 2020

Nov 16, 2020

BUY
$8.09 - $16.25 $19.5 Million - $39.2 Million
2,411,403 New
2,411,403 $21.4 Million

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $811M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.